239 related articles for article (PubMed ID: 26762111)
1. Yin Yang 1 promotes mTORC2-mediated AKT phosphorylation.
Zhang Q; Wan M; Shi J; Horita DA; Miller LD; Kute TE; Kridel SJ; Kulik G; Sui G
J Mol Cell Biol; 2016 Jun; 8(3):232-43. PubMed ID: 26762111
[TBL] [Abstract][Full Text] [Related]
2. Characterization of YY1 OPB Peptide for its Anticancer Activity.
Qi Y; Yan T; Chen L; Zhang Q; Wang W; Han X; Li D; Shi J; Sui G
Curr Cancer Drug Targets; 2019; 19(6):504-511. PubMed ID: 30381079
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT.
Zhao L; Li R; Gan YH
Cell Death Dis; 2018 Jul; 9(7):747. PubMed ID: 29970878
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W.
Jeon YH; Park YH; Kwon JH; Lee JH; Kim IY
Biochim Biophys Acta; 2013 Oct; 1833(10):2135-42. PubMed ID: 23680186
[TBL] [Abstract][Full Text] [Related]
5. IBP-mediated suppression of autophagy promotes growth and metastasis of breast cancer cells via activating mTORC2/Akt/FOXO3a signaling pathway.
Chen S; Han Q; Wang X; Yang M; Zhang Z; Li P; Chen A; Hu C; Li S
Cell Death Dis; 2013 Oct; 4(10):e842. PubMed ID: 24113176
[TBL] [Abstract][Full Text] [Related]
6. PRICKLE1 Contributes to Cancer Cell Dissemination through Its Interaction with mTORC2.
Daulat AM; Bertucci F; Audebert S; Sergé A; Finetti P; Josselin E; Castellano R; Birnbaum D; Angers S; Borg JP
Dev Cell; 2016 May; 37(4):311-325. PubMed ID: 27184734
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of mTORC2 activation by the selective agonist of EPAC, 8-CPT-2Me-cAMP, in prostate cancer cells: assembly of a multiprotein signaling complex.
Misra UK; Pizzo SV
J Cell Biochem; 2012 May; 113(5):1488-500. PubMed ID: 22173835
[TBL] [Abstract][Full Text] [Related]
8. Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers.
Morrison Joly M; Hicks DJ; Jones B; Sanchez V; Estrada MV; Young C; Williams M; Rexer BN; Sarbassov dos D; Muller WJ; Brantley-Sieders D; Cook RS
Cancer Res; 2016 Aug; 76(16):4752-64. PubMed ID: 27197158
[TBL] [Abstract][Full Text] [Related]
9. A Positive Feedback Loop between Akt and mTORC2 via SIN1 Phosphorylation.
Yang G; Murashige DS; Humphrey SJ; James DE
Cell Rep; 2015 Aug; 12(6):937-43. PubMed ID: 26235620
[TBL] [Abstract][Full Text] [Related]
10. Runx2 activates PI3K/Akt signaling via mTORC2 regulation in invasive breast cancer cells.
Tandon M; Chen Z; Pratap J
Breast Cancer Res; 2014 Jan; 16(1):R16. PubMed ID: 24479521
[TBL] [Abstract][Full Text] [Related]
11. YY1 Oligomerization Is Regulated by Its OPB Domain and Competes with Its Regulation of Oncoproteins.
Qiao S; Wang W; Yi C; Xu Q; Wang W; Shi J; Stovall DB; Li D; Sui G
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406384
[TBL] [Abstract][Full Text] [Related]
12. ERK1/2-dependent activation of mTOR/mTORC1/p70S6K regulates thrombin-induced RPE cell proliferation.
Parrales A; López E; Lee-Rivera I; López-Colomé AM
Cell Signal; 2013 Apr; 25(4):829-38. PubMed ID: 23291002
[TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide-dependent kinase 1 and mTORC2 synergistically maintain postnatal heart growth and heart function in mice.
Zhao X; Lu S; Nie J; Hu X; Luo W; Wu X; Liu H; Feng Q; Chang Z; Liu Y; Cao Y; Sun H; Li X; Hu Y; Yang Z
Mol Cell Biol; 2014 Jun; 34(11):1966-75. PubMed ID: 24662050
[TBL] [Abstract][Full Text] [Related]
14. Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes.
Pentassuglia L; Heim P; Lebboukh S; Morandi C; Xu L; Brink M
Am J Physiol Endocrinol Metab; 2016 May; 310(9):E782-94. PubMed ID: 26979522
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt.
Zhang J; Xu K; Liu P; Geng Y; Wang B; Gan W; Guo J; Wu F; Chin YR; Berrios C; Lien EC; Toker A; DeCaprio JA; Sicinski P; Wei W
Mol Cell; 2016 Jun; 62(6):929-942. PubMed ID: 27237051
[TBL] [Abstract][Full Text] [Related]
16. IKK interacts with rictor and regulates mTORC2.
Xu Y; Lai E; Liu J; Lin J; Yang C; Jia C; Li Y; Bai X; Li M
Cell Signal; 2013 Nov; 25(11):2239-45. PubMed ID: 23872070
[TBL] [Abstract][Full Text] [Related]
17. Blocking of YY1 reduce neutrophil infiltration by inhibiting IL-8 production via the PI3K-Akt-mTOR signaling pathway in rheumatoid arthritis.
Lin J; He Y; Wang B; Xun Z; Chen S; Zeng Z; Ou Q
Clin Exp Immunol; 2019 Feb; 195(2):226-236. PubMed ID: 30229869
[TBL] [Abstract][Full Text] [Related]
18. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
19. Identification of the general transcription factor Yin Yang 1 as a novel and specific binding partner for S6 kinase 2.
Ismail HM; Myronova O; Tsuchiya Y; Niewiarowski A; Tsaneva I; Gout I
Cell Signal; 2013 May; 25(5):1054-63. PubMed ID: 23403125
[TBL] [Abstract][Full Text] [Related]
20. PI3K/Akt promotes feedforward mTORC2 activation through IKKα.
Dan HC; Antonia RJ; Baldwin AS
Oncotarget; 2016 Apr; 7(16):21064-75. PubMed ID: 27027448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
